Carsten Reinhardt
Bielefeld University(DE)Essen University Hospital(DE)West German Heart and Vascular Center Essen(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)University of Duisburg-Essen(DE)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Research and Treatments, Immunotherapy and Immune Responses, Biomedical Ethics and Regulation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody(2008)1,067 cited
- → Actively personalized vaccination trial for newly diagnosed glioblastoma(2018)910 cited
- → Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival(2011)905 cited
- → Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival(2012)780 cited
- → Bispecific T-Cell Engaging Antibodies for Cancer Therapy(2009)583 cited
- → IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial